Wow - approved on the basis of a 31% overall response rate ( which includes complete and partial responses ).
Brings me back to this chart which I marked up during the AGM as Dr Tillett was speaking.
https://hotcopper.com.au/posts/41576170/single
https://www.fda.gov/drugs/fda-appro...ry-acute-myeloid-leukemia-aml-flt3-mutatation
-
- There are more pages in this discussion • 10,250 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.015(1.22%) |
Mkt cap ! $215.4M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.23 | $106.2K | 85.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 11900 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 819 | 1 |
View Market Depth
| Last trade - 15.56pm 26/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |